8-KRegulation FD

Elevance Health, Inc. 8-K Report, Regulation FD Disclosure (Jan 3, 2007)

Filed January 3, 2007For Securities:ELV

Summary

Elevance Health, Inc. (then operating as WellPoint, Inc.) filed this Form 8-K on January 3, 2007, to disclose that company officers would be meeting with securities analysts and investors. The primary purpose of these meetings was to reaffirm the company's ability to meet previously communicated earnings expectations. These expectations were established in earlier press releases and investor calls on December 12, 2006, and October 25, 2006. This filing suggests a proactive approach by WellPoint to manage investor sentiment and provide confidence in its financial performance during the specified period. Investors would look to this confirmation as a sign of stability and predictability in the company's earnings trajectory, particularly given the specific dates mentioned, indicating ongoing communication and commitment to guidance.

Key Highlights

  • 1WellPoint, Inc. (now Elevance Health) confirmed ability to meet earnings expectations.
  • 2Earnings expectations were previously communicated on December 12, 2006, and October 25, 2006.
  • 3Company officers were scheduled to meet with securities analysts and investors.
  • 4The meetings were set to occur between January 3, 2007, and January 18, 2007.
  • 5This 8-K serves as a Regulation FD disclosure, ensuring consistent information dissemination.
  • 6The filing reaffirms guidance provided in earlier press releases and conference calls.

Frequently Asked Questions

The main purpose of this 8-K filing is to disclose that company officers would be meeting with securities analysts and investors and to reaffirm the company's ability to meet its previously communicated earnings expectations.

The original earnings expectations were set in a press release and webcast on December 12, 2006, and in a press release and conference call on October 25, 2006.

Regulation FD (Fair Disclosure) is an SEC rule that requires public companies to make broad and non-exclusionary public disclosure of material non-public information. This 8-K filing, under Item 7.01, is an example of such a disclosure to ensure all investors have access to the same information.

The 8-K filing was signed by Angela F. Braly, Executive Vice President, General Counsel and Chief Public Affairs Officer of WellPoint, Inc.